Search This Blog

Thursday, February 2, 2023

U.S. FDA removes COVID test requirements for Pfizer, Merck pills

 The U.S. Food and Drug Administration (FDA) on Wednesday removed the need for a positive test for COVID-19 treatments from Pfizer Inc (PFE.N) and Merck & Co Inc (MRK.N).

Pfizer's Paxlovid and Merck's Lagevrio pills were given emergency use authorizations in Dec. 2021 for patients with mild-to-moderate COVID who tested positive for the virus, and who were at risk of progressing to severe COVID.

Still, the FDA said the patients should have a current diagnosis of mild-to-moderate COVID infection.

The health regulator said individuals with recent known exposure with signs and symptoms may be diagnosed by their healthcare providers with COVID even if they have a negative test result.

https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-removes-covid-test-requirements-pfizer-merck-pills-2023-02-01/

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.